Lung Cancer 2017 Jun
Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy: A secondary analysis of the Phase III CREST trial.
Related Questions
Would you consider it for a patient who had bulky thoracic disease, with limited extrathoracic disease at diagnosis and achieved a CR after induction ...
New comment by Radiation Oncologist at Pikeville Medical Center ( August 20, 2024)
If all nodal sites had resolved and there was a small residual disease remaining, would you go back and treat the mediastinum? Or just what you can see on post chemoimmunother...
If so, what fields do you irradiate? The initially involved nodal regions? Do you offer after PR as well? If not, do you consolidate at any point...
New answer by Radiation Oncologist at Cleveland Clinic (December 4, 2020)
Overall, my clinical practice mirrors that of Dr. @Andrew T. Turrisi's answer based on subset analysis of the CREST trial suggesting that the patients who benefited the most w...